Logo image
Metagenomic polymorphic toxin effector and immunity profiling predicts microbiome development and disease-related dysbiosis
Preprint   Open access

Metagenomic polymorphic toxin effector and immunity profiling predicts microbiome development and disease-related dysbiosis

Hunter W Schroer, Francesco Beghini, Juan Antonio Raygoza Garay, Nicholas A Christakis and Dustin E. Bosch
bioRxiv
Cold Spring Harbor Laboratory, 1.1
07/08/2025
DOI: 10.1101/2025.07.08.662037
PMCID: PMC12265584
PMID: 40672213
url
https://doi.org/10.1101/2025.07.08.662037View
Preprint (Author's original)This preprint has not been evaluated by subject experts through peer review. Preprints may undergo extensive changes and/or become peer-reviewed journal articles. Open Access

Abstract

Bacteria use antagonistic interbacterial weapons such as polymorphic toxin secretion systems (TSS) to compete for niches in the human gut microbiome. We developed a bioinformatic marker gene approach (PolyProf) to quantify TSS including ∼200 effector and immunity genes and applied it to ∼15,000 publicly available human metagenomes. PolyProf alpha and beta diversity readily distinguished 12 different human disease states. Decision tree machine learning models integrating bacterial taxonomy with PolyProf had near-perfect accuracy (ROC area 1.00) for all 12 disease states. During microbiome development in the first year of life, PolyProf alpha diversity increases, and beta diversity becomes increasingly like the maternal microbiome, influenced by vertical transfer, delivery mode, and breastfeeding. PolyProf is related to strain sharing among adults through social interactions. In summary, interbacterial antagonism with TSS shapes microbiome development and interpersonal strain sharing. Since PolyProf distinguishes diverse adult disease statuses, these dynamics may contribute to non-genetic inheritance.
Microbiology

Details

Metrics

36 Record Views
Logo image